메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
저널정보
거트앤리버 발행위원회 Gut and Liver Gut and Liver 제8권 제3호
발행연도
2014.1
수록면
248 - 253 (6page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background/Aims: Knowledge of the risk factors associatedwith adverse outcomes after percutaneous endoscopicgastrostomy (PEG) may be helpful for developing PEG recommendations. The purpose of this study was to identify theclinical risk factors associated with adverse clinical outcomesafter PEG, especially regarding the use of proton pump inhibitors(PPIs). Methods: We retrospectively reviewed the datafrom PEG patients at seven university hospitals betweenJune 2006 and January 2012. All patients were followed upthrough February 2012 after PEG, and the clinical risk factorsfor adverse clinical outcomes after PEG were analyzed. Results: Data from 1,021 PEG patients were analyzed. PPIusers were more frequently included in the complicationgroup than the noncomplication group (p=0.040). PEG-relatedcomplications (p=0.040) and mortality (p=0.003) weremore frequent in the PPI group than in the control group. Inthe subgroup analysis of complicated PEG cases, infectiouscomplications were more frequently found in the PPI groupthan in the control group (35.8% vs 27.8%). After adjustmentfor multiple possible confounding factors, PPI users (oddsratio, 1.531; 95% confidence interval, 1.017 to 2.305) anddiabetic patients had increased mortality after PEG. Conclusions:PPI use may be associated with adverse outcomes inpatients with PEG; however, further prospective studies investigatingthis issue are warranted.

목차

등록된 정보가 없습니다.

참고문헌 (25)

참고문헌 신청

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0